{
    "clinical_study": {
        "@rank": "96029", 
        "arm_group": {
            "arm_group_label": "cervical dystonia", 
            "arm_group_type": "Experimental", 
            "description": "cervical dsytonia patinets"
        }, 
        "brief_summary": {
            "textblock": "Objective:  To determine if the calcium channel blockers, amlodipine can augment the effect\n      of botulinum toxin injections in the treatment  of focal dystonia.\n\n      Study Population:  20 patients with cervical dystonia\n\n      Design: Double-bind, placebo-controlled clinical trail.\n\n      Outcome measures:  For patients: dystonia rating scales (Twistrs, Fahn-Marsden dystonia\n      scale, NINDS subjective patient rating scale), and hand grip strength. For healthy\n      volunteers:  Amplitude of EDB MEP."
        }, 
        "brief_title": "Amlodipine Plus Botulinum Toxin for Focal Dystonia", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "All participants enrolled in study", 
                        "title": "Cervical Dystonia"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "16"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "0"
                                            }
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "15"
                                            }
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "1"
                                            }
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "description": "age >18", 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "13"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "3"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Rating scale assessing sum of severity of dystonia, disability score and pain scale.  Ordinal scale ranging from 0 (least severe) to 30 (maximally severe).  Score is maximal response TWSTR rating minus baseline rating.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients receiving Amlodipine plus botulinum toxin injections during either period.", 
                                    "title": "Amlodipine"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients receiving Placebo plus botulinum toxin injections during either period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "11"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "10.23", 
                                                        "@value": "-6.00"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "6.06", 
                                                        "@value": "-3.23"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Rating scale assessing sum of severity of dystonia, disability score and pain scale.  Ordinal scale ranging from 0 (least severe) to 30 (maximally severe).  Score is maximal response TWSTR rating minus baseline rating.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Toronto Western Spasmodic Torticollis Rating Scale (TWSTR) Sum Score", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Total enrolled less withdrawals from study.  One participant completed the study but did not yield analyzeable data", 
                        "safety_issue": "No", 
                        "time_frame": "1-2 month maximal rating", 
                        "title": "Toronto Western Spasmodic Torticollis Rating Scale (TWSTR) Sum Score", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Self reported duration of effect in weeks.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients receiving Amlodipine plus botulinum toxin injections during either period.", 
                                    "title": "Amlodipine"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients receiving Placebo plus botulinum toxin injections during either period.", 
                                    "title": "Placebo"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "11"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "11"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "1", 
                                                        "@upper_limit": "12", 
                                                        "@value": "6"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "2", 
                                                        "@upper_limit": "12", 
                                                        "@value": "5.5"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Self reported duration of effect in weeks.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Duration of Response to Botulinum Toxin Injection With Amlodipine and With Placebo", 
                                    "units": "weeks"
                                }
                            ]
                        }, 
                        "population": "Total enrolled less withdrawals.  Less one participant who completed the study but who did not yield analyzeable data.", 
                        "safety_issue": "No", 
                        "time_frame": "3 months", 
                        "title": "Duration of Response to Botulinum Toxin Injection With Amlodipine and With Placebo", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Patients with cervical dystonia receiving botulinum toxin injections plus Amlodipine during the first period and botulinum toxin injections plus Placebo during the second period.", 
                            "title": "Amlodipine Then Placebo"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Patients with cervical dystonia receiving botulinum toxin injections plus Placebo during the first period and botulinum toxin injections plus Amlodipine during the second period.", 
                            "title": "Placebo Then Amlodipine"
                        }
                    ]
                }, 
                "period_list": {
                    "period": [
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "2", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Adverse Event"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "Lack of Efficacy"
                                    }
                                ]
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "8", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "8", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "8", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "3", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "First Intervention"
                        }, 
                        {
                            "drop_withdraw_reason_list": {
                                "drop_withdraw_reason": {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }
                            }, 
                            "milestone_list": {
                                "milestone": [
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "8", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "STARTED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "7", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "5", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "COMPLETED"
                                    }, 
                                    {
                                        "participants_list": {
                                            "participants": [
                                                {
                                                    "@count": "1", 
                                                    "@group_id": "P1"
                                                }, 
                                                {
                                                    "@count": "0", 
                                                    "@group_id": "P2"
                                                }
                                            ]
                                        }, 
                                        "title": "NOT COMPLETED"
                                    }
                                ]
                            }, 
                            "title": "Second Intervention"
                        }
                    ]
                }, 
                "pre_assignment_details": "Patients were excluded if response to previous btx injections were not stable, serious medical conditions, pregnancy, abnormal medical screening", 
                "recruitment_details": "Patients recruited from a medical clinic providing botulinum toxin treatment for cervical dystonia.  Patients recruited between 6/21/01 and 10/19/06"
            }, 
            "point_of_contact": {
                "email": "karpb@ninds.nih.gov", 
                "name_or_title": "Barbara I Karp, MD", 
                "organization": "National Institutes of Health", 
                "phone": "301-496-0150"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Patients receiving Amlodipine plus botulinum toxin injections during either period.", 
                            "title": "Amlodipine"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Patients receiving Placebo plus botulinum toxin injections during either period.", 
                            "title": "Placebo"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "16"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "16"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "16"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "16"
                                            }
                                        ], 
                                        "sub_title": "hypereosinophila"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "16"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "16"
                                            }
                                        ], 
                                        "sub_title": "dysphagia"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "16"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "16"
                                            }
                                        ], 
                                        "description": "ankle edema", 
                                        "sub_title": "swelling"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "frequency_threshold": "0"
                }
            }
        }, 
        "condition": "Focal Dystonia", 
        "condition_browse": {
            "mesh_term": [
                "Dystonia", 
                "Dystonic Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "Objective:  To determine if the calcium channel blocker, amlodipine can augment the effect\n      of botulinum toxin injections in the treatment  of focal dystonia.\n\n      Study Population:  20 patients with cervical dystonia\n\n      Design: Double-bind, placebo-controlled clinical trail.\n\n      Outcome measures:  dystonia rating scales (TWISTRS)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Patients enrolled in Protocol 85-N-0195, Efficacy and Pathophysiology of Botulinum Toxin\n        for Treatment of Involuntary Movement Disorders are eligible for enrollment if they meet\n        the following inclusion and exclusion criteria.\n\n        Good general health\n\n        Focal hand dystonia or cervical dystonia\n\n        Stable response to botulinum toxin demonstrated through a series of at least 3 injections\n        over a period of at least a year\n\n        Benefit from the 3 immediately prior btx injections rated as 75% or less or a duration of\n        benefit lasting less than or equal to 2 months\n\n        No other medications for dystonia\n\n        EXCLUSION CRITERIA:\n\n        Cervical dystonia accompanied by dysphagia or dyspnea, either before or with botulinum\n        toxin injection\n\n        Present or past cardiac disease, hypertension, arrhythmia or congestive heart failure\n\n        Anterocollis or other neck dystonia requiring bilateral anterior neck muscle injections\n\n        Use of concomitant medications affecting calcium channels or those metabolized by the\n        cytochrome p450 3A4 system including grapefruit juice, St. John's wort, HIV protease\n        inhibitors, cimetidine, antibiotics (macrolides, fluoroquinones, antifungal, rifampin),\n        antidepressants (fluvoxamine, norfluoxetine), barbiturates, anticonvulsants\n        (carbamazepine, phenytoin), oral diabetes agents (pioglitazone, troglitazone), and\n        glucocorticoids\n\n        Allergy to amlodipine or related compounds\n\n        Pregnany/ nursing\n\n        Age less than 18 years of age\n\n        Abnormal EKG\n\n        Abnormal coagulation  profile or liver function tests\n\n        Use  of anticoagulants"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 18, 2001", 
        "firstreceived_results_date": "March 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00015457", 
            "org_study_id": "010147", 
            "secondary_id": "01-N-0147"
        }, 
        "intervention": {
            "arm_group_label": "cervical dystonia", 
            "description": "N/A", 
            "intervention_name": "Amlodipine plus Botulinum toxin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins", 
                "Amlodipine", 
                "Calcium Channel Blockers"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Writer's Cramp", 
            "Calcium Channel Antagonists", 
            "Torticollis", 
            "Chemodenervation"
        ], 
        "lastchanged_date": "March 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2009", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Rating scale assessing sum of severity of dystonia, disability score and pain scale.  Ordinal scale ranging from 0 (least severe) to 30 (maximally severe).  Score is maximal response TWSTR rating minus baseline rating.", 
            "measure": "Toronto Western Spasmodic Torticollis Rating Scale (TWSTR) Sum Score", 
            "safety_issue": "No", 
            "time_frame": "1-2 month maximal rating"
        }, 
        "reference": [
            {
                "PMID": "9783280", 
                "citation": "Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg. 1998 Sep;14(5):305-17."
            }, 
            {
                "PMID": "2300249", 
                "citation": "Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990 Feb;40(2):277-80."
            }, 
            {
                "PMID": "2213039", 
                "citation": "Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):633-9."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00015457"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institutes of Health Clinical Center (CC)", 
            "investigator_full_name": "Barbara Karp, M.D.", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Self reported duration of effect in weeks.", 
            "measure": "Duration of Response to Botulinum Toxin Injection With Amlodipine and With Placebo", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "April 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}